Endothelial cells are susceptible to rapid siRNA transfection and gene silencing ex vivo

Journal of Vascular Surgery

Volumn 52, Issue 6, 2010, Pages 1608-1615

  Andersen, Nicholas D ^a   Chopra, Atish ^a   Monahan, Thomas S ^a   Malek, Junaid Y ^a   Jain, Monica ^b   Pradhan, Leena ^a   Ferran, Christiane ^a   Logerfo, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; SMALL INTERFERING RNA;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HYPERBARISM; IMMUNOHISTOCHEMISTRY; OPERATING ROOM; PRIORITY JOURNAL; SAPHENOUS VEIN;

AIR PRESSURE; ENDOTHELIUM, VASCULAR; GENE SILENCING; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SAPHENOUS VEIN; TISSUE CULTURE TECHNIQUES; TRANSFECTION;

EID: 78650217876     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.06.169     Document Type: Article

References (29)

1. N.D. Andersen, T.S. Monahan, J.Y. Malek, M. Jain, S. Daniel, and L.D. Caron Comparison of gene silencing in human vascular cells using small interfering RNAs J Am Coll Surg 204 2007 399 408
2. T.S. Monahan, N.D. Andersen, M.C. Martin, J.Y. Malek, G.V. Shrikhande, and L. Pradhan MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein FASEB J 23 2009 557 564
3. M.S. Conte, M.J. Mann, H.F. Simosa, K.K. Rhynhart, and R.C. Mulligan Genetic interventions for vein bypass graft disease: a review J Vasc Surg 36 2002 1040 1052
4. R.J. Esper, R.A. Nordaby, J.O. Vilarino, A. Paragano, J.L. Cacharron, and R.A. Machado Endothelial dysfunction: a comprehensive appraisal Cardiovasc Diabetol 5 2006 4
5. G.M. Rubanyi The role of endothelium in cardiovascular homeostasis and diseases J Cardiovasc Pharmacol 22 Suppl 4 1993 S1 S14
6. V.E. Friedewald, T.D. Giles, J.L. Pool, C.W. Yancy, and W.C. Roberts The Editor's Roundtable: endothelial dysfunction in cardiovascular disease Am J Cardiol 102 2008 418 423
7. M.J. Mann, G.H. Gibbons, H. Hutchinson, R.S. Poston, E.G. Hoyt, and R.C. Robbins Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues Proc Natl Acad Sci U S A 96 1999 6411 6416
8. J.R. Ramos, K. Berger, P.B. Mansfield, and L.R. Sauvage Histologic fate and endothelial changes of distended and nondistended vein grafts Ann Surg 183 1976 205 228
9. L.E. Boerboom, G.N. Olinger, L.I. Bonchek, I.I. Gunay, A.H. Kissebah, and E.R. Rodriguez The relative influence of arterial pressure versus intraoperative distention on lipid accumulation in primate vein bypass grafts J Thorac Cardiovasc Surg 90 1985 756 764
10. F.W. LoGerfo, W.C. Quist, H.M. Crawshaw, and C. Haudenschild An improved technique for preservation of endothelial morphology in vein grafts Surgery 90 1981 1015 1024
11. A. Chatterjee, S.M. Black, and J.D. Catravas Endothelial nitric oxide (NO) and its pathophysiologic regulation Vascul Pharmacol 49 2008 134 140
12. A.A. Soyombo, G.D. Angelini, A.J. Bryan, B. Jasani, and A.C. Newby Intimal proliferation in an organ culture of human saphenous vein Am J Pathol 137 1990 1401 1410
13. A.A. Soyombo, G.D. Angelini, A.J. Bryan, and A.C. Newby Surgical preparation induces injury and promotes smooth muscle cell proliferation in a culture of human saphenous vein Cardiovasc Res 27 1993 1961 1967
14. S. Kirkeby, and C.E. Thomsen Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software J Immunol Methods 301 2005 102 113
15. K.A. Matkowskyj, D. Schonfeld, and R.V. Benya Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab J Histochem Cytochem 48 2000 303 312
16. S.T. Hollenbeck, K. Sakakibara, P.L. Faries, B. Workhu, B. Liu, and K.C. Kent Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway J Surg Res 120 2004 288 294
17. J.C. Russ The image processing handbook 2nd ed. 1995 CRC Press Boca Raton
18. A. de Fougerolles, M. Manoharan, R. Meyers, and H.P. Vornlocher RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics Methods Enzymol 392 2005 278 296
19. A. Aigner Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo J Biomed Biotechnol 2006 2006 71659
20. M. Miyagishi, M. Hayashi, and K. Taira Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells Antisense Nucleic Acid Drug Dev 13 2003 1 7
21. P. Sundaram, B. Echalier, W. Han, D. Hull, and L. Timmons ATP-binding cassette transporters are required for efficient RNA interference in Caenorhabditis elegans Mol Biol Cell 17 2006 3678 3688
22. J.D. Mannion, M.L. Ormont, Y. Shi, J.E. O'Brien Jr, W. Chung, and F. Roque Saphenous vein graft protection: effects of c-myc antisense J Thorac Cardiovasc Surg 115 1998 152 161
23. T. Kodama, P.H. Tan, I. Offiah, T. Partridge, T. Cook, and A.J. George Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles Ultrasound Med Biol 31 2005 1683 1691
24. M.S. Conte, D.F. Bandyk, A.W. Clowes, G.L. Moneta, L. Seely, and T.J. Lorenz Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery J Vasc Surg 43 2006 742 751 discussion 751
25. J.H. Alexander, G. Hafley, R.A. Harrington, E.D. Peterson, T.B. Ferguson Jr, and T.J. Lorenz Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454
26. F.W. LoGerfo, C.C. Haudenschild, and W.C. Quist A clinical technique for prevention of spasm and preservation of endothelium in saphenous vein grafts Arch Surg 119 1984 1212 1214
27. M.J. Mann, A.D. Whittemore, M.C. Donaldson, M. Belkin, M.S. Conte, and J.F. Polak Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Lancet 354 1999 1493 1498
28. N.D. Desai, and S.E. Fremes Efficacy and safety of edifoligide JAMA 295 2006 1514 author reply 1514-5
29. G. Dorn, S. Patel, G. Wotherspoon, M. Hemmings-Mieszczak, J. Barclay, and F.J. Natt siRNA relieves chronic neuropathic pain Nucleic Acids Res 32 2004 e49